backgroundvirus
detect
patient
acut
respiratori
infect
may
caus
ill
asymptomat
shed
objectiveto
estim
attribut
fraction
af
detect
rate
attribut
ill
differ
respiratori
virus
studi
designw
compar
preval
common
respiratori
virus
influenza
b
virus
parainfluenza
viru
respiratori
syncyti
viru
rsv
adenoviru
rhinoviru
human
metapneumoviru
hmpv
enteroviru
hiv
posit
neg
patient
hospit
sever
acut
respiratori
ill
sari
outpati
influenzalik
ill
ili
control
subject
report
febril
respiratori
gastrointestin
ill
south
africa
resultsw
enrol
sari
ili
control
hiv
seropreval
respect
influenza
viru
af
ci
hmpv
af
ci
rsv
af
ci
infect
associ
sever
diseas
rhinoviru
af
ci
adenoviru
af
ci
moder
associ
conclusionsinfluenza
rsv
hmpv
consid
pathogen
detect
ili
sari
rhinoviru
adenoviru
commonli
identifi
control
suggest
may
caus
proport
clinic
diseas
observ
posit
patient
nonetheless
may
import
contributor
diseas
pneumonia
lead
caus
childhood
mortal
global
million
new
case
per
year
million
occur
develop
world
approxim
sever
enough
requir
hospit
worldwid
avail
vaccin
streptococcu
pneumonia
pneumococcu
haemophilu
influenza
type
b
identifi
main
bacteri
caus
pneumonia
virus
commonli
detect
patient
acut
respiratori
infect
includ
pneumonia
use
sensit
pcr
method
significantli
expand
abil
laboratori
detect
identifi
pathogen
clinic
associ
pathogen
detect
diseas
remain
difficult
interpret
consid
viral
shed
replic
persist
nucleic
acid
present
preor
postsyndrom
phase
infect
absenc
comparison
group
without
compar
control
group
clinic
relev
identifi
respiratori
pathogen
pcr
test
remain
difficult
determin
understand
contribut
respiratori
virus
ill
would
allow
priorit
respiratori
pathogen
inclus
diagnost
test
diseas
surveil
vaccin
develop
treatment
attribut
fraction
common
respiratori
virus
among
patient
hospit
sever
acut
respiratori
ill
sari
outpati
influenzalik
ill
ili
compar
control
subject
sari
surveillancestudi
sampl
obtain
particip
enrol
prospect
hospitalbas
surveil
program
sari
initi
februari
methodolog
case
definit
studi
previous
describ
studi
particip
enrol
public
hospit
provinc
south
africa
edendal
hospit
kwazulunat
provinc
klerksdorp
tshepong
hospit
north
west
provinc
may
april
ili
control
surveillancestudi
sampl
obtain
particip
enrol
activ
surveil
program
ili
control
initi
may
run
april
methodolog
case
definit
studi
previous
describ
patient
present
ili
control
enrol
two
outpati
clinic
catchment
area
mention
hospit
edendal
gateway
clinic
kwazulunat
provinc
jouberton
clinic
north
west
provinc
ili
case
defin
outpati
age
present
either
temperatur
histori
fever
cough
durat
day
control
defin
individu
present
outpati
clinic
histori
fever
respiratori
gastrointestin
symptom
day
preced
visit
aim
enrol
one
hivinfect
one
hivuninfect
control
everi
week
clinic
within
follow
age
categori
year
nasopharyng
aspir
children
year
age
nasopharyng
oropharyng
swab
individu
year
age
collect
enrol
patient
sari
ili
control
place
viral
transport
medium
store
specimen
test
presenc
respiratori
virus
influenza
b
virus
parainfluenza
viru
piv
type
respiratori
syncyti
viru
rsv
adenoviru
rhinoviru
human
metapneumoviru
hmpv
enteroviru
use
realtim
revers
transcriptas
polymeras
chain
reaction
rrtpcr
assay
among
consent
studi
patient
hiv
statu
establish
enzymelink
immunosorb
assay
elisa
pcr
assay
depend
patient
age
implement
multivari
multinomi
regress
model
determin
associ
specif
respiratori
virus
among
patient
sari
ili
compar
control
enrol
may
april
multinomi
regress
allow
model
outcom
variabl
categori
relat
probabl
categori
j
probabl
baselin
refer
categori
complet
set
coeffici
estim
j
level
patient
ili
sari
analysi
compar
baselin
categori
control
analysi
effect
predictor
model
measur
rel
risk
ratio
rrr
associ
virus
mild
ili
sever
sari
ill
assess
simultan
use
multivari
model
adjust
potenti
effect
coinfect
addit
estim
adjust
age
year
age
hiv
serostatu
underli
medic
condit
hiv
addit
implement
agestratifi
analysi
among
individu
age
year
age
evalu
potenti
differ
diseas
associ
young
children
older
individu
analys
also
adjust
effect
viral
covari
age
within
age
strata
year
age
children
age
year
year
age
person
age
year
hiv
serostatu
underli
medic
condit
hiv
subsequ
estim
attribut
fraction
af
rel
risk
rr
obtain
multinomi
model
viru
use
follow
formula
af
rr
lastli
adjust
observ
detect
rate
prev
ob
nn
viru
among
ili
sari
case
correspond
af
obtain
preval
viru
attribut
mild
ili
sever
sari
ill
adjust
preval
prev
ill
use
follow
formula
prev
ill
prev
ob
analysi
perform
use
stata
statacorp
texa
usa
studi
period
enrol
sari
case
ili
case
control
main
unstratifi
analysi
use
multivari
multinomi
regress
virus
except
adenoviru
significantli
associ
mild
ill
ili
virus
except
associ
sever
ill
sari
tabl
nonetheless
level
associ
ie
magnitud
af
vari
across
pathogen
among
ili
case
af
highest
influenza
adjust
af
aaf
confid
interv
ci
aaf
ci
hmpv
aaf
ci
tabl
among
sari
case
af
highest
influenza
aaf
ci
hmpv
aaf
ci
rsv
aaf
ci
tabl
age
stratifi
analysi
among
children
year
age
virus
except
adenoviru
enteroviru
significantli
associ
mild
ill
ili
virus
except
associ
sever
ill
sari
tabl
among
sari
case
year
age
highest
signific
af
observ
influenza
hmpv
rsv
lowest
signific
af
observ
enteroviru
tabl
group
among
virus
signific
af
estim
detect
rate
attribut
ill
adjust
preval
rsv
rhinoviru
adenoviru
hmpv
influenza
enteroviru
tabl
among
individu
year
age
adenoviru
rsv
significantli
associ
mild
ill
ili
adenoviru
hmpv
significantli
associ
sever
ill
sari
tabl
among
sari
case
year
age
highest
signific
af
observ
enteroviru
influenza
lowest
signific
af
observ
rhinoviru
group
among
virus
signific
af
estim
detect
rate
attribut
ill
rhinoviru
influenza
rsv
enteroviru
tabl
among
ili
case
influenza
highest
af
estim
preval
associ
ill
among
children
year
af
prev
ill
well
individu
year
af
prev
ill
tabl
assess
associ
viru
detect
mild
sever
ill
rel
control
estim
detect
rate
attribut
ill
report
studi
reflect
accur
descript
preval
virus
caus
respiratori
diseas
children
adult
south
africa
report
viral
detect
rate
alon
viral
pathogen
evalu
studi
found
associ
mild
sever
diseas
irrespect
hiv
statu
nonetheless
magnitud
associ
vari
pathogen
studi
suggest
influenza
rsv
hmpv
infect
highli
associ
sever
respiratori
ill
south
africa
rel
control
especi
children
year
age
mirror
find
self
et
al
rhinoviru
adenoviru
lowest
estim
af
estim
detect
rate
attribut
ill
remain
high
indic
virus
could
act
pathogen
bystand
could
also
respons
substanti
proport
sever
diseas
rsv
rhinoviru
adenoviru
hmpv
influenza
common
pathogen
caus
diseas
among
sari
case
especi
children
year
age
find
differ
similar
studi
use
multiplex
pcr
detect
viral
aetiolog
noninvas
respiratori
specimen
rel
control
group
fewer
virus
associ
diseas
studi
conduct
among
children
year
age
hospit
pneumonia
kilifi
district
hospit
kenya
report
rsv
identifi
case
associ
diseas
well
casecontrol
studi
conduct
among
children
month
rural
kenya
convers
anoth
studi
conduct
children
report
rsv
influenza
commonli
found
among
case
control
adult
rsv
influenza
hmpv
shown
associ
diseas
note
studi
limit
number
control
potenti
result
lack
power
detect
signific
diseas
associ
pathogen
low
detect
rate
studi
rsv
found
significantli
associ
sever
respiratori
diseas
rel
control
rsv
well
document
lead
caus
viral
pneumonia
children
year
age
also
increasingli
recogn
caus
sever
diseas
adult
sever
studi
shown
rsv
infect
import
caus
ill
elderli
year
highrisk
adult
diseas
burden
similar
nonpandem
season
influenza
although
found
rsv
associ
diseas
among
children
adult
model
studi
conduct
south
africa
found
excess
mortal
hospit
associ
rsv
among
adult
appar
contradict
may
relat
fact
burden
rsv
among
older
adult
south
africa
may
low
detect
model
studi
rhinoviru
shown
less
associ
ill
low
attribut
fraction
children
adult
estim
detect
rate
attribut
ill
remain
elev
compar
pathogen
suggest
rhinoviru
may
still
caus
substanti
proport
clinic
diseas
manifest
either
ili
sari
high
preval
rhinoviru
among
control
indic
rhinoviru
may
potenti
extend
shed
period
detect
patient
without
symptom
sever
studi
report
high
posit
rate
rhinoviru
asymptomat
individu
none
far
abl
give
clear
indic
rhinoviru
role
sever
respiratori
infect
although
sever
suggest
rhinoviru
act
bystand
pathogen
similar
result
obtain
adenoviru
studi
studi
influenza
hmpv
found
significantli
associ
sever
diseas
among
children
less
year
age
influenza
describ
one
lead
caus
pneumonia
children
elderli
adult
hiv
infect
sinc
hmpv
report
worldwid
howev
far
studi
hmpv
limit
although
suggest
hmpv
mirror
epidemiolog
rsv
influenza
sever
infect
occur
young
elderli
immunecompromis
individu
studi
limit
warrant
discuss
first
sever
virus
detect
low
preval
control
group
would
account
high
adjust
rel
risk
ratio
also
wide
confid
interv
second
compar
detect
rate
pathogen
among
symptomat
patient
control
prove
disprov
diseas
associ
individu
patient
approach
viral
load
host
interact
need
determin
role
virus
play
sever
respiratori
diseas
take
account
factor
replic
persist
nucleic
acid
present
preor
post
syndrom
phase
infect
third
adjust
potenti
role
bacteri
infect
inform
avail
role
bacteri
superinfect
sever
ill
follow
viral
infect
exclud
last
wherea
multivari
analysi
adjust
hiv
serostatu
individu
enrol
studi
power
provid
estim
af
stratifi
hiv
due
low
detect
rate
certain
pathogen
within
stratum
conclus
influenza
rsv
hmpv
consid
like
pathogen
detect
south
african
patient
ili
sari
wherea
rhinoviru
adenoviru
commonli
identifi
also
among
control
suggest
may
caus
proport
clinic
diseas
observ
posit
patient
nonetheless
given
high
estim
detect
rate
attribut
ill
may
import
contributor
diseas
data
togeth
match
casecontrol
studi
like
perch
pneumonia
etiolog
research
child
health
provid
use
inform
pathogen
impact
diseas
sever
may
assist
better
interpret
surveil
data
priorit
pathogen
includ
surveil
program
guid
prevent
intervent
tabl
associ
respiratori
virus
among
children
year
age
sari
ili
compar
control
south
africa
control
case
use
refer
group
multinomi
regress
model
arrr
highlight
bold
indic
factor
signific
p
